The U.S. Food and Drug Administration has announced the recall of Regal King brands ready-to-eat seafood dips because of possible Listeria contamination.
Ocean King Enterprises Inc. of Philadelphia said the products were distributed by retail stores in the Hatfield, Maine, Woodbridge, N.J., and Baltimore areas.
Listeria monocytogenes infections can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
The FDA said the products were sold in bulk 5-pound containers to various distribution warehouses where the dips were sent to retail stores in clear plastic containers with a Regal King Gourmet Seafood label. All flavors have a red and white repack label and include Premium Krab Dip, Cajun Krab Dip, Shrimp Dip, and Smoked Salmon Dip.
Consumers with questions can contact Ocean King Enterprises Inc. at 215-495-0540.
Copyright 2007 by United Press International
Related stories:
Opening a can of worms: Serendipitous discovery reveals earthworms more diverse than first thought
Scientists have found that the UK's common or garden earthworms are far more diverse than previously thought, a discovery with important consequences for agriculture.
DNA could reveal your surname
(PhysOrg.com) -- Scientists at the world-leading Department of Genetics at the University of Leicester – where the revolutionary technique of genetic fingerprinting was invented by Professor Sir Alec Jeffreys- are developing techniques which may one day allow police to work out someone's surname from the DNA alone.
Under pressure at the nanoscale, polymers play by different rules
Scientists putting the squeeze on thin films of polystyrene have discovered that at very short length scales the polymer doesn't play by the rules.
Burger King switches to trans fat free oil
(AP) -- Burger King Corp. said Thursday it is now cooking with trans fat free cooking oils at all of its restaurants nationwide.
Philips develops ultrasound-activated microbubbles for localized delivery of cancer drugs
(PhysOrg.com) -- Philips is developing an ultrasound-based drug delivery technology that is designed to increase the effectiveness and reduce the side effects of chemotherapy treatment for certain types of cancer.
Embryo implantation offers insight into infertility
(PhysOrg.com) -- A process that governs embryo implantation in the womb in humans has been identified for the first time. The Oxford University research, published in the journal PNAS, could shed light on what goes wrong when embryos fail to implant in the lining of the womb, a leading cause of infertility.
Microsoft chief optimistic despite US economic meltdown
Microsoft chief executive Steve Ballmer says he is confident the technology industry is buffered from the US economic crisis.
Neuroscientist reveals how nonconformists achieve success
In a new book,
Iconoclast: A Neuroscientist Reveals How to Think Differently (Harvard Business Press, 2008), Gregory Berns, MD, PhD, shows us how the world's most successful innovators think and what we can learn from them.